Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Magnetic resonance imaging sequences such as diffusion and spectroscopy have been well studied in X-linked adrenoleukodystrophy, but no data exist on magnetic resonance perfusion imaging. Since inflammation is known to modulate the microcirculation, we investigated the hypothesis that changes in the local perfusion might be one of the earliest signs of lesion development. Twenty patients with different phenotypes of adrenoleukodystrophy and seven age-matched controls were evaluated between 2006 and 2011. Fluid attenuated inversion recovery, post-contrast T(1)-weighted and normalized dynamic susceptibility contrast magnetic resonance perfusion cerebral blood volume maps were co-registered, segmented when cerebral lesion was present, and normalized cerebral blood volume values were analysed using a Food and Drug Association approved magnetic resonance perfusion software (NordicICE). Clinical and imaging data were reviewed to determine phenotype and status of progression. All eight patients with cerebral adrenoleukodystrophy had an average 80% decrease in normalized cerebral blood volume at the core of the lesion (P < 0.0001). Beyond the leading edge of contrast enhancement cerebral perfusion varied, patients with progressive lesions showed an average 60% decrease in normalized cerebral blood volume (adults P < 0.05; children P < 0.001), while one child with arrested progression normalized cerebral blood volume in this region. In six of seven patients with cerebral adrenoleukodystrophy lesions and follow-up imaging (2-24 month interval period), we found progression of contrast enhancement into the formerly hypoperfused perilesional zone. Asymptomatic, adrenomyeloneuropathy and female heterozygote patients had no significant changes in cerebral perfusion. Our data indicate that decreased brain magnetic resonance perfusion precedes leakage of the blood-brain barrier as demonstrated by contrast enhancement in cerebral adrenoleukodystrophy and is an early sign of lesion progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human histopathology and perfusion studies suggest that microvascular dysfunction and increased BBB-permeability precede active demyelination4,5.”
From Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When cerebral disease progresses, the contrast-enhancement region moves into areas of previously decreased perfusion, suggesting the shunting of perfusion from adjacent areas to sites of active inflammation, early tissue injury, or dysfunction of the neurovascular unit [419].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [419]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, regional increases in these flow disturbances precede progression of the active demyelination5,9–11.”
From Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy (2023) · cites this paper as [5]
In the citing paper
“Indeed, dynamic susceptibility contrast MR (DSC-MR) perfusion studies in ALD patients have shown that ABCD1 dysfunction alters white matter capillary flow and limits the metabolic rate of oxygen.”
From Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy (2023) · cites this paper as [5]
In the citing paper
“Cerebral blood volume, assessed by susceptibility contrast MRI (Musolino et al., 2012), or CBF, assessed by single photon emission tomography (Suhaili et al., 1994), is reduced in the normal appearing and abnormal white matter.”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Musolino et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,453
Boxerman, J. L., Schmainda, K. M., & Weisskoff, R. M. (2006) · PubMed · Cited by 686
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
Adrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases
Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475
Adrenoleukodystrophy: a scoring method for brain MR observations.
(1994) · PubMed Central · Cited by 321
Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy
Loes, D. J., Fatemi, A., Melhem, E. R., Gupte, N., Bezman, L., Moser, H. W., & Raymond, G. V. (2003) · Neurology · doi:10.1212/01.wnl.0000079050.91337.83 · Cited by 268 · cited 1×
“Neuroimaging studies are exquisitely sensitive in detecting the initial plaque of the expanding confluent lesion (Moser et al., 2000; Loes et al., 2003).”
BackgroundLaw, M., Saindane, A. M., Ge, Y., Babb, J. S., Johnson, G., Mannon, L. J., Herbert, J., & Grossman, R. I. (2004) · Radiology · doi:10.1148/radiol.2313030996 · Cited by 242
Wuerfel, J. (2004) · Brain · doi:10.1093/brain/awh007 · Cited by 225
Research works printed but not linked: 4
- Loes, 1994, American Journal of Neuroradiology, 15, 1761
- Melhem, 2000, American Journal of Neuroradiology, 21, 839
- 1935, ARCH NEUROL NEUROPSYCHOL, 32, 1298
- van Geel, 2001, Annals of neurology, 49, 186, 10.1002/1531-8249(20010201)49:2<186::aid-ana38>3.0.co;2-r · doi:10.1002/1531-8249(20010201)49:2<186::aid-ana38>3.0.co;2-r
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Pathophysiology of X-linked adrenoleukodystrophy
Berger, J., Forss-Petter, S., & Eichler, F. S. (2014) · Biochimie · doi:10.1016/j.biochi.2013.11.023 · Cited by 238
Self-citationTurk, B. R., Theda, C., Fatemi, A., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 210
X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Bergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94
“…correlation with data from prior autopsy and longitudinal MRI studies with regard to the typical evolution and spread of lesions (Eichler et al., 2009; Loes et al., 1994; Loes et al., 2003; Musolino et al., 2012; Schaumburg, Powers, Raine, Suzuki, & Richardson, 1975; van der Knaap & Valk, 2005).”
BackgroundResultInfluentialBrain endothelial dysfunction in cerebral adrenoleukodystrophy
Musolino, P. L., Gong, Y., Snyder, J. M. T., Jimenez, S., Lok, J., Lo, E. H., Moser, A. B., Grabowski, E. F., Frosch, M. P., & Eichler, F. S. (2015) · Brain · doi:10.1093/brain/awv250 · Cited by 92
Self-citationAdenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy
Gong, Y., Mu, D., Prabhakar, S., Moser, A., Musolino, P., Ren, J., Breakefield, X. O., Maguire, C. A., & Eichler, F. S. (2015) · Molecular Therapy · doi:10.1038/mt.2015.6 · Cited by 74
Self-citationWeber, F. D., Wiesinger, C., Forss-Petter, S., Regelsberger, G., Einwich, A., Weber, W. H. A., Kohler, W., Stockinger, H., & Berger, J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt645 · Cited by 63
Lee, C. A. A., Seo, H. S., Armien, A. G., Bates, F. S., Tolar, J., & Azarin, S. M. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0094-5 · Cited by 52
ABCD1 dysfunction alters white matter microvascular perfusion
Lauer, A., Da, X., Hansen, M. B., Boulouis, G., Ou, Y., Cai, X., Liberato Celso Pedrotti, A., Kalpathy-Cramer, J., Caruso, P., Hayden, D. L., et al. (2017) · Brain · doi:10.1093/brain/awx262 · Cited by 48
Self-citationMusolino, P. L., Lund, T. C., Pan, J., Escolar, M. L., Paker, A. M., Duncan, C., & Eichler, F. (2014) · Neuropediatrics · doi:10.1055/s-0033-1364179 · Cited by 48
Self-citationImaging in X-Linked Adrenoleukodystrophy
van de Stadt, S. I. W., Huffnagel, I. C., Turk, B. R., van der Knaap, M. S., & Engelen, M. (2021) · Neuropediatrics · doi:10.1055/s-0041-1730937 · Cited by 30
Richmond, P. A., van der Kloet, F., Vaz, F. M., Lin, D., Uzozie, A., Graham, E., Kobor, M., Mostafavi, S., Moerland, P. D., Lange, P. F., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00520 · Cited by 29
Krishna, S. H., McKinney, A. M., & Lucato, L. T. (2013) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2013.10.008 · Cited by 30
Lauer, A., Speroni, S. L., Choi, M., Da, X., Duncan, C., McCarthy, S., Krishnan, V., Lusk, C. A., Rohde, D., Hansen, M. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37262-w · Cited by 26
Self-citationAdvances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
Zhou, L., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101357 · Cited by 26
Therapeutic strategies in adrenoleukodystrophy
Turk, B. R., Moser, A. B., & Fatemi, A. S. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0534-2 · Cited by 26
SIRT1 activation alleviates brain microvascular�endothelial dysfunction in peroxisomal disorders
Zhang, Y., Cui, G., Wang, Y., Gong, Y., & Wang, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4250 · Cited by 24
Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy
Pierpont, E. I., Nascene, D. R., Shanley, R., Kenney-Jung, D. L., Ziegler, R. S., Miller, W. P., Gupta, A. O., Lund, T. C., Orchard, P. J., & Eisengart, J. B. (2020) · Neurology · doi:10.1212/wnl.0000000000009929 · Cited by 21
Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma
Bouquet, F., Dehais, C., Sanson, M., Lubetzki, C., & Louapre, C. (2015) · Neurology · doi:10.1212/wnl.0000000000002173 · Cited by 19
Presymptomatic Lesion in Childhood Cerebral Adrenoleukodystrophy: Timing and Treatment
Mallack, E. J., van Haren, K. P., Torrey, A. C., van de Stadt, S. I. W., Engelen, M., Raymond, G. V., Fatemi, A. S., & Eichler, F. (2022) · Neurology · doi:10.1212/wnl.0000000000200571 · Cited by 17
Self-citationTurk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.11.002 · Cited by 19
Mallack, E. J., Askin, G., van de Stadt, S. I. W., Caruso, P. A., Musolino, P. L., Engelen, M., Niogi, S. N., & Eichler, F. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7250 · Cited by 14
Self-citationLund, T. C., Ng, M., Orchard, P. J., Loes, D. J., Raymond, G. V., Gupta, A., Kenny-Jung, D., & Nascene, D. R. (2020) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2020.06.019 · Cited by 12
McKinney, A. M., Benson, J., Nascene, D. R., Eisengart, J., Salmela, M. B., Loes, D. J., Zhang, L., Patel, K., Raymond, G. V., & Miller, W. P. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4773 · Cited by 12
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy
Bougnères, P., & Le Stunff, C. (2025) · Genes · doi:10.3390/genes16050590 · Cited by 11
X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES
Furlan, F. L. S., Lemes, M. A., Suguimatsu, L. C. F., Pires, C. T. F., & Santos, M. L. S. F. (2019) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/;2019;37;4;00015 · Cited by 15
Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy
Lin, J. E., Armour, E. A., Heshmati, A., Umandap, C. H., Couto, J. J., Iglesias, A. D., Mallack, E. J., & Bain, J. (2019) · Neurology · doi:10.1212/wnl.0000000000007755 · Cited by 11
Stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives
Miller, W. P. (2017) · Journal of Neurorestoratology · doi:10.2147/jn.s99304 · Cited by 7
Metabolic, endocrine, and other genetic disorders
Dahmoush, H., Melhem, E. R., & Vossough, A. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00063-6 · Cited by 6
Wright, M. A., Demmitt-Rice, C. E., van Haren, K. P., Lund, T. C., Eichler, F., & Bonkowsky, J. L. (2025) · Journal of Child Neurology · doi:10.1177/08830738251353034 · Cited by 5
Self-citationMyelin-water imaging and multi-shell diffusion-weighted imaging in adults with adrenoleukodystrophy
Yska, H. A. F., Stellingwerff, M. D., Roosendaal, S. D., Voermans, M. M. C., van der Knaap, M. S., Pouwels, P. J. W., & Engelen, M. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf371 · Cited by 6
Yska, H. A. F., Golse, M., Galanaud, D., Amartino, H. M., Bergner, C. G., Bruschi, F., Eichler, F., Fatemi, A. S., García‐Cazorla, À., Gómez‐Chiari, M., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000214657 · Cited by 6
Self-citationSinghapakdi, K., Sharma, K., & Maertens, P. M. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1727143 · Cited by 3
Zhang, L., Yu, Y. F., Liu, T., Li, C., Tan, L., & Wen, S. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03499-x · Cited by 2
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00001-0
Metadata
- Authors
- Musolino, P. L., Rapalino, O., Caruso, P., Caviness, V. S., & Eichler, F. S.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-09-01
- Volume
- 135
- Issue
- 9
- Pages
- 2676-2683
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3437030
- OpenAlex
- W2127566889
- Cited by
- 37
- References
- 24
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 4
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (K12NS066225, K08NS052550, K08NS52550, R01NS072446, R25NS065743)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- X-linked adrenoleukodystrophy, cerebral hypoperfusion, cerebral blood volume, lesion progression, brain perfusion imaging, dynamic susceptibility contrast MRI, blood-brain barrier disruption, adrenomyeloneuropathy, female heterozygotes
- MeSH terms
- Adolescent, Adrenoleukodystrophy, Adult, Aged, Blood-Brain Barrier, Brain, Brain Mapping, Cerebrovascular Circulation, Child, Child, Preschool, Humans, Magnetic Resonance Imaging, Male, Microcirculation, Middle Aged, Nerve Fibers, Myelinated, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.